More than 2,000 life science industry insiders around the globe participated in the WuXi Global Forum on Jan. 9, 2018 during the annual J.P. Morgan Healthcare Conference in San Francisco. The standing-room only event, which was also webcast live around the world, brought together industry leaders to discuss the rapid advances and changes impacting the industry, from the most disruptive therapeutic interventions to artificial intelligence to the evolving global regulatory landscape.
The year 2017 set the stage for great things in the life science industry, including a resurgence of capital, landmark policy reforms, record drug approvals, record funding and deals, and advanced technologies like AI. Dr. Ge Li, Chairman of WuXi AppTec Group, reiterated that 2017 was a history-making year for life science and posed the question to the audience, “Will 2018 be another history-making year?,” which was an overarching theme during the three-hour conference.
During his welcoming remarks, the Honorable Jim Greenwood, president and CEO, Biotechnology Innovation Organization (BIO), pointed out that no country has a monopoly on the financial or human capital that 21st century innovation requires; and the business realities of our industry require us to be collaborators. He also explained how advances in genomics, precision medicine and regenerative biology have brought us to the doorstep of a new golden era of treatments and cures, but our future isn’t guaranteed without good policies and global collaborations.
During the lively, thought-provoking panel discussions, a wide range of panelists discussed how start-ups are tackling tough diseases; how regulatory reforms are accelerating new drug approval; the next hot areas in life sciences; and how AI and deep learning will impact drug R&D and the future of health.
Below are some highlights:
Indeed, 2018 will be full of great advances, challenges, and even some surprises as we work together to foster global partnerships to bring more hope to patients worldwide. WuXi looks forward to collaborating with our partners and customers again this year to fulfill our ultimate dream that “every drug can be made and every disease can be treated.”
WuXi would like to thank our Global Forum co-hosts 6 Dimensions Capital, BayHelix, BioCentury, BioWorld, ChinaBio, CLSA, Informa, MBC BioLabs, QB3, Sina Medicine, and SVIEF.
To view the WuXi Global Forum 2018 webcast, please click here